Normal view MARC view ISBD view

Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential.

D'Haese, Jan G

Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. [electronic resource] - Expert opinion on therapeutic targets Feb 2010 - 207-19 p. digital

Publication Type: Journal Article; Review

ISSN: 1744-7631

Standard No.: 10.1517/14728220903540265 doi

Subjects--Topical Terms:
Animals
Chemokine CX3CL1--antagonists & inhibitors
Humans
Inflammation--etiology
Neoplasms--drug therapy
Pain--drug therapy
Pancreatic Diseases--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)